Your shopping cart is currently empty

CTSLCTSB-IN-1 (Compound212-148) is a dual-specificity inhibitor targeting the host virus spike cleavage proteins CTSL/CTSB and TMPRSS2, with IC50 values of 2.13/64.07 nM and 1.38 μM, respectively. By inhibiting the cleavage of viral spike proteins, CTSLCTSB-IN-1 obstructs two critical entry pathways of the SARS-CoV-2 virus, making it useful for anti-SARS-CoV-2 research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | CTSLCTSB-IN-1 (Compound212-148) is a dual-specificity inhibitor targeting the host virus spike cleavage proteins CTSL/CTSB and TMPRSS2, with IC50 values of 2.13/64.07 nM and 1.38 μM, respectively. By inhibiting the cleavage of viral spike proteins, CTSLCTSB-IN-1 obstructs two critical entry pathways of the SARS-CoV-2 virus, making it useful for anti-SARS-CoV-2 research. |
| In vitro | CTSLCTSB-IN-1 demonstrates significant antiviral activity in Calu-3 cells infected with clinically isolated SARS-CoV-2 δ or omicron BA.2 strains at concentrations of (10 -3 -10 5 nM, 1h). |
| Formula | C41H47N7O6S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.